Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 651 to 675 of 2529

TitleReference numberPublishedLast updated
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Romosozumab for treating severe osteoporosisTA791
Endoanchoring systems in endovascular aortic aneurysm repairHTG625
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritisHTG626
Sleepio to treat insomnia and insomnia symptomsHTG624
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeHTG623
Vaccine uptake in the general populationNG218
Vaccine uptake in under 19sQS145
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295
Granulox for managing chronic non-healing woundsMIB296
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Liposuction for chronic lymphoedemaHTG622
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Intramedullary distraction for upper limb lengtheningHTG621

Results per page

  1. 10
  2. 25
  3. 50
  4. All